Seer’s Post

Join us at #ASGCT24, where we will showcase our neurology-focused pre-clinical pipeline, including data supporting innovations in zinc finger epigenetic regulation, advances in AAV capsid engineering, and discovery of our next-generation integrase technology.   Details here on our 20 abstracts that will be presented, https://bit.ly/3wf1Aai #genomemedicine #neurology #epigenetics #zincfinger

The recent AI surge has reignited excitement around precision medicine, but the fundamentals of validation and translation remain unchanged. Next week I’ll be sharing how we’re leveraging LLMs with real-world data to minimize diagnostic hallucinations and using in vivo models to rapidly validate disease drivers. If you’re attending the meeting, let’s connect! #ai #drugdiscovery

It’s important that participants in Alzheimer’s disease (AD) clinical trials reflect the real-world population of people who are most likely to develop AD. Dung Trinh, MD, Chief Medical Officer at the Healthy Brain Clinic, explains why while highlighting the communities that have historically been underserved in this collaborative video series with Biogen. Learn more about Eisai’s commitment to AD research here: https://ow.ly/J5Ii50ThvwI #AlzheimersDisease #healthequity #neurology

Why is #genomics important in #neurology and how is it being applied in a clinical setting? In our video, Professor Huw Morris outlines the increasing role of genomics and some of things neurologists should be aware of. View the full resource here: https://buff.ly/3vfmqWE

Why is #genomics important in #neurology and how is it being applied in a clinical setting? In our video, Professor Huw Morris outlines the increasing role of genomics and some of things neurologists should be aware of. View the full resource here: https://buff.ly/3YdrKUT

December's #EANPOTM: Breaking New Ground in MND Research The MND-SMART trial explored the safety and efficacy of memantine and trazodone in treating motor neuron disease (MND). While neither drug significantly slowed disease progression or improved survival, this innovative platform trial design highlights the future of clinical research—efficient, adaptable, and patient-centered. Key Details: ➡️Tested Drugs: Memantine (20 mg), Trazodone (200 mg) ➡️554 patients across 20 UK centers ➡️Results: Safe, well-tolerated, but no efficacy at tested doses. Learn more about the trial and its implications for neurology research: https://ow.ly/CVQw50UoSL3 #EANeurology #Neurology #MNDresearch #MND

Interested in genomic testing in child neurology? Watch this 3.5-hour webinar, presented by 11 global experts and cohosted by Baylor Genetics & Illumina. You will learn all values of genomic sequencing in the diagnosis & treatment of child neurology. #WGS#NGS#Neurology

Our recent webinar, co-hosted with Illumina, highlights the diagnostic, clinical, and economic impacts of genomic sequencing for neurological indications in children. Watch the replay here: https://lnkd.in/ggsp-kJx #ThinkBG #Neurology

Researchers at Massachusetts Institute of Technology, led by Jason Hou, Md Md Osman Goni Nayeem, and Canan Dagdeviren, have introduced a groundbreaking approach to deep brain stimulation (DBS). Their novel method utilizes ultrasound through the ImPULS (Implantable Piezoelectric Ultrasound Stimulator), offering potential advantages such as reduced tissue damage and enhanced neuron stimulation in the substantia nigra. Published in Nature Communications, this research paves the way for safer and more effective therapies in Parkinson's treatment. 🔍 I aim to keep you informed with the most relevant and up-to-date information to help enhance understanding and management of Parkinson's Disease. Check out my latest newsletter for more in-depth insights and the latest advancements in treatment and research. #ParkinsonsResearch #DeepBrainStimulation #Neurology #MedicalInnovation #Healthcare #MITResearch Abbott Fiona Gupta MD Alfonso Fasano Giuseppe Bonavina A/Professor Dr. Shohreh Majd Milena Korostenskaja, PhD Frank Telang MD Dr Kevin Reji Shadi Sharifi Nabil Akkawi, MD Karoly Vadasdi Mary Alissa Willis, MD, FAAN, FANA Mustafa Shakra

Andy Hay, President of Sysmex America, Inc., discusses critical challenges facing hematology laboratories today, with Sonia Nicholas, SelectScience®. Watch this insightful conversation to hear Hay's thoughts on staffing shortages, consolidation and declining reimbursements. Find out how companies like Sysmex are focusing on automation, AI and partnerships to improve care, and learn more about exciting new developments in neurology ... https://lnkd.in/eANmkTYx #hematology #haematology #sysmex #medicallaboratory #clinicallaboratory #clinicaldiagnostics #AI #healthcare #neurology #CLINICAL24